The importance of mTORC1 signaling in T-cell lymphoma (but not MPD or AML) pathogenesis was suggested by the significantly increased survival observed when myr-Akt mice were treated with rapamycin. Here, AKT1 is linked to T-cell non-Hodgkin lymphoma.